Cargando…

Effect of Protein Genotypes on Physicochemical Properties and Protein Functionality of Bovine Milk: A Review

Milk protein comprises caseins (CNs) and whey proteins, each of which has different genetic variants. Several studies have reported the frequencies of these genetic variants and the effects of variants on milk physicochemical properties and functionality. For example, the C variant and the BC haplot...

Descripción completa

Detalles Bibliográficos
Autores principales: Gai, Nan, Uniacke-Lowe, Therese, O’Regan, Jonathan, Faulkner, Hope, Kelly, Alan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535582/
https://www.ncbi.nlm.nih.gov/pubmed/34681458
http://dx.doi.org/10.3390/foods10102409
Descripción
Sumario:Milk protein comprises caseins (CNs) and whey proteins, each of which has different genetic variants. Several studies have reported the frequencies of these genetic variants and the effects of variants on milk physicochemical properties and functionality. For example, the C variant and the BC haplotype of α(S1)-casein (α(S1)-CN), β-casein (β-CN) B and A(1) variants, and κ-casein (κ-CN) B variant, are favourable for rennet coagulation, as well as the B variant of β-lactoglobulin (β-lg). κ-CN is reported to be the only protein influencing acid gel formation, with the AA variant contributing to a firmer acid curd. For heat stability, κ-CN B variant improves the heat resistance of milk at natural pH, and the order of heat stability between phenotypes is BB > AB > AA. The A(2) variant of β-CN is more efficient in emulsion formation, but the emulsion stability is lower than the A(1) and B variants. Foaming properties of milk with β-lg variant B are better than A, but the differences between β-CN A(1) and A(2) variants are controversial. Genetic variants of milk proteins also influence milk yield, composition, quality and processability; thus, study of such relationships offers guidance for the selection of targeted genetic variants.